Working… Menu

SARC024: A Blanket Protocol to Study Oral Regorafenib in Patients With Selected Sarcoma Subtypes

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT02048371
Recruitment Status : Recruiting
First Posted : January 29, 2014
Last Update Posted : August 10, 2021
Information provided by (Responsible Party):
Sarcoma Alliance for Research through Collaboration